Skip to main content
OpenTrials
Enrolling by invitation

NCT Number: NCT07830550

Blood Donation Study for ALPCO Syphilis-T and Syphilis-NT Assay Development

This prospective, single-center study will collect blood from approximately 50 adult volunteers aged 22 years or older. Participants will provide informed consent, complete an eligibility review, and undergo one blood draw of approximately 20-50 mL.

The blood will be processed into serum and labeled with a study identification number. The serum may be used to prepare laboratory samples with defined antibody levels to support the development and performance evaluation of the ALPCO Syphilis-T and Syphilis-NT assays. All testing is for research purposes only. Individual test results will not be provided to participants or used for diagnosis or treatment.

Enrolling by invitation

Interested in participating?

Request Info

Key information

About this study

Syphilis is a sexually transmitted infection caused by the bacterium Treponema pallidum. Laboratory diagnosis commonly includes treponemal tests, which detect antibodies specific to T. pallidum, and non-treponemal tests, which detect antibodies associated with cellular damage and may help assess disease activity.

Serum collected under this study will serve as a human serum matrix for preparing contrived specimens. These specimens may be created by adding characterized reactive serum or other appropriately characterized materials to produce predefined levels of treponemal or non-treponemal reactivity. Before use, the serum may be evaluated using appropriate reference or comparator methods to confirm its suitability.

The resulting specimens will support analytical and, when scientifically and regulatorily appropriate, clinical performance evaluations of the ALPCO Syphilis-T and Syphilis-NT assays. The specific preparation procedures, target reactivity levels, testing methods, and acceptance criteria will be defined in the applicable performance-study protocols.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male or female adults aged 22 years or older
  • Able and willing to provide written informed consent
  • Able and willing to provide a blood sample in accordance with the protocol

Exclusion criteria

  • Unable or unwilling to provide written informed consent
  • Unable or unwilling to undergo venipuncture
  • Any medical condition that would make blood collection unsafe, as determined by study personnel

Treatment and study plan

ALPCO Syphilis-T

Device

Approximately 20-50 mL of whole blood will be collected during one study visit by qualified personnel using standard venipuncture procedures. The blood will be processed to obtain serum for research use in developing and evaluating the ALPCO Syphilis-T and Syphilis-NT assays.

ALPCO Syphilis-NT CLIA Kits

Device

Detection of antibodies to lipoidal antigens in human serum and plasma

Primary outcomes

  1. Number of Blood Specimens Successfully Processed Into Serum

    Time frame: Day 1, following the single study visit and serum processing

    The number of enrolled participants from whom approximately 20-50 mL of whole blood is successfully collected and processed into serum suitable for research use in the development and performance evaluation of the ALPCO Syphilis-T and Syphilis-NT assays.

Sponsors and collaborators

Lead sponsor

American Laboratory Products Company

Industry

Registry information

Official study title

ALPCO Syphilis-T (Treponema Pallidum) CLIA Kit and ALPCO Syphilis-NT (Non-Treponemal Lipoidal Antigen) CLIA Kit Blood Donation Protocol

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
Sep 21, 2026
Registry last updated
Sep 22, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.